Osteoblastic Responses to LPS, Glucose-oxidised LDL and Minocycline: Therapeutic Targets for Periodontal and Cardiometabolic Diseases

Publisher： Bentham Science Publishers

E-ISSN： 2212-3334|6|1|73-84

ISSN： 1872-2148

Source： Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol.6, Iss.1, 2012-01, pp. : 73-84

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Relevance of Dyslipidaemia and its Consequences in Periodontal Patients with Co-Existing Cardiovascular Disease and Diabetes Mellitus: Therapeutic Targets

By  

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 3, Iss. 3, 2009-11 ,pp. : 214-224

Bentham Science Publishers

Access to resources Recommend Favorite

Chemokines as Novel Therapeutic Targets in Autoimmune Thyroiditis

By  

Recent Patents on DNA & Gene Sequences, Vol. 4, Iss. 1, 2010-01 ,pp. : 52-57

Bentham Science Publishers

Access to resources Recommend Favorite

GLUT4 Associated Proteins as Therapeutic Targets for Diabetes

By  

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 5, Iss. 1, 2011-01 ,pp. : 25-32

Bentham Science Publishers

Access to resources Recommend Favorite

The Potentials of Selected Therapeutic Targets for Inflammation: A Snapshot

By  

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 6, Iss. 2, 2012-05 ,pp. : 137-146

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Hypothermia in Brain Injuries and Related Diseases

By  

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 5, Iss. 2, 2011-05 ,pp. : 155-164

Bentham Science Publishers

Access to resources Recommend Favorite